Divalproex sodium in the treatment of adults with bipolar disorder

Academic Article

Abstract

  • Divolproex sodium (Depokote┬«, Abbott Laboratories) is an antilconvulsant with well-established efficacy in the treatment of bipolar I disorder, manic or mixed episode. Over the past 10 years, an increased number of studies indicate that divalproex has a broad spectrum of activity in the treatment of bipolar depression and rapid cycling, psychotic symptoms, impulsive aggression and post-traumatic stress disorder. Newer formulations of divalproex, namely the extended-release formulation, are now available. The improved tolerability and convenience of the once-daily extended-release formulation has a significant potential to improve patient compliance and thus, clinical and functional outcomes. The use of divalproex in the treatment of bipolar and other related psychiatric disorders is reviewed.
  • Authors

    Published In

    Digital Object Identifier (doi)

    Author List

  • Davis LL; Williams R; Cates M
  • Start Page

  • 349
  • End Page

  • 362
  • Volume

  • 4
  • Issue

  • 3